S
IRLA

SignatureFD’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

SignatureFD’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– -$1K – 3288
2021
Q4 		– Sell
-3
Closed -$18.3K – 2976
2021
Q3 		$59K Hold
3
– – ﹤0.01% 1231
2021
Q2 		$34K Hold
3
– – ﹤0.01% 1465
2021
Q1 		$22K Hold
3
– – ﹤0.01% 1542
2020
Q4 		$14K Sell
3
-3
-50% -$26.6K ﹤0.01% 1579
2020
Q3 		$55K Hold
6
– – ﹤0.01% 944
2020
Q2 		$52K Buy
+6
New +$55K ﹤0.01% 935

Other funds holding IRLA

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SignatureFD's IRLA Position: Q1 2022 in Review

SignatureFD held its IRulya Therapeutics Inc. Common Stock (IRLA) position steady in Q1 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

SignatureFD first reported a position in IRLA in Q2 2020 and has held it in 6 quarters since. The position peaked at $59K in Q3 2021. 85 funds tracked by Wall St. Rank hold IRLA as of Q1 2022.

  • SignatureFD held 0 shares of IRulya Therapeutics Inc. Common Stock worth $0 as of Q1 2022.
  • SignatureFD left its IRulya Therapeutics Inc. Common Stock share count unchanged in Q1 2022.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of SignatureFD's portfolio in Q1 2022, its #3288 holding.
  • SignatureFD first reported a position in IRulya Therapeutics Inc. Common Stock in Q2 2020 and has held it in 6 quarters since.
  • SignatureFD's IRulya Therapeutics Inc. Common Stock position peaked at $59K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2022.

Based on SignatureFD's 13F filing for Q1 2022, filed 2 May 2022.